BioSpace News Archive

Synlogic announced that Aoife Brennan, M.B., B.Ch., Synlogic’s interim president and chief executive officer, and chief medical officer, will present a corporate update at the 2018 Wedbush PacGrow Healthcare Conference at 3:05pm ET on Tuesday, August 14, 2018, in New York City.

Achieved Revenue Growth of 106%

American Renal Associates Holdings, Inc. announced financial and operating results for the second quarter ended June 30, 2018.

Dr. Thomas Cannell Appointed President and Chief Executive Officer as Company Advances Toward Potential BLA Submission and Commercialization of Vicinium™

Conference call begins today at 4:30 p.m. Eastern time

Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today reported financial results for the second quarter ended June 30, 2018 and provided a corporate update.

Under Argentina’s Presidency of the G20, leading economies in Latin America need to step up their contributions to fight against global AIDS and other related public-health threats

Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates for neurodegenerative diseases, today announced that Dr. Dana Andersen has joined the company as Chief Technical and Manufacturing Officer.

Merck announced the retirement effective November 30, 2018 of its chief human resources officer Mirian M. Graddick-Weir, following 12 years of service with the company.

Advancing Development Programs for Remote Robotics and Neurovascular Applications